Daniela Ulgiati

Dr. Daniela Ulgiati


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2010 in Amino Acids
Verified
Journal Article
Closed access
PDF file
MCMark N. Cruickshank
Mark N. Cruickshank
PBPaul Besant
Paul Besant
DUDaniela Ulgiati
Daniela Ulgiati

6 October 2009 in Immunology & Cell Biology
Verified
Journal Article
Closed access
MCMark Cruickshank
Mark Cruickshank
DUDaniela Ulgiati
Daniela Ulgiati

21 May 2019 in Human Mutation
Verified
Journal Article
Open access
PDF file
IHIsabel A. Hemming
Isabel A. Hemming
OCOlivier Clément
Olivier Clément
IGIvan E. Gladwyn‐Ng
Ivan E. Gladwyn‐Ng
HCHayley D. Cullen
Hayley D. Cullen
HNHan Leng Ng
Han Leng Ng
JHJulian I‐T. Heng
Julian I‐T. Heng
The activities of DNA‐binding transcription factors, such as the multi‐zinc finger protein ZBTB18 (also known as RP58, or ZNF238), are essential to coordinate mammalian neurodevelopment, including the birth and radial migration of newborn neurons within the fetal brain. In humans, the majority of disease‐associated missense mutations in ZBTB18 lie within the DNA‐binding zinc finger domain and are associated with brain developmental disorder, yet the molecular mechanisms explaining their role in disease remain unclear. To address this, we developed in silico models of ZBTB18 bound to DNA, and discovered that half of the missense variants map to residues (Asn461, Arg464, Glu486) predicted to be essential to sequence‐specific DNA contact, while others map to residues (Leu434, Tyr447, Arg495) with limited contributions to DNA binding. We studied pathogenic variants to residues with close (N461S) and limited (R495G) DNA contact and found that each bound DNA promiscuously, displayed altered transcriptional regulatory activity in vitro, and influenced the radial migration of newborn neurons in vivo in different ways. Taken together, our results suggest that altered transcriptional regulation could represent an important pathological mechanism for ZBTB18 missense variants in brain developmental disease.

7 June 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
HNHan Leng Ng
Han Leng Ng
EQElizabeth Quail
Elizabeth Quail
MCMark Cruickshank
Mark Cruickshank
DUDaniela Ulgiati
Daniela Ulgiati
Notch signaling forms an evolutionarily conserved juxtacrine pathway crucial for cellular development. Initially identified in Drosophila wing morphogenesis, Notch signaling has since been demonstrated to play pivotal roles in governing mammalian cellular development in a large variety of cell types. Indeed, abolishing Notch constituents in mouse models result in embryonic lethality, demonstrating that Notch signaling is critical for development and differentiation. In this review, we focus on the crucial role of Notch signaling in governing embryogenesis and differentiation of multiple progenitor cell types. Using hematopoiesis as a diverse cellular model, we highlight the role of Notch in regulating the cell fate of common lymphoid progenitors. Additionally, the influence of Notch through microenvironment interplay with lymphoid cells and how dysregulation influences disease processes is explored. Furthermore, bi-directional and lateral Notch signaling between ligand expressing source cells and target cells are investigated, indicating potentially novel therapeutic options for treatment of Notch-mediated diseases. Finally, we discuss the role of cis-inhibition in regulating Notch signaling in mammalian development.

1 October 2012 in Molecular Immunology
Verified
Journal Article
Closed access
MCMark N. Cruickshank
Mark N. Cruickshank
MKMahdad Karimi
Mahdad Karimi
RMRhonda L. Mason
Rhonda L. Mason
EFEmily Fenwick
Emily Fenwick
TMTim Mercer
Tim Mercer
DUDaniela Ulgiati
Daniela Ulgiati

13 June 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
JCJessica Cheng
Jessica Cheng
JCJoshua S. Clayton
Joshua S. Clayton
RARafael D. Acemel
Rafael D. Acemel
YZYe Zheng
Ye Zheng
RTRhonda L. Taylor
Rhonda L. Taylor
DUDaniela Ulgiati
Daniela Ulgiati
The Regulators of Complement Activation (RCA) gene cluster comprises several tandemly arranged genes with shared functions within the immune system. RCA members, such as complement receptor 2 (CR2), are well-established susceptibility genes in complex autoimmune diseases. Altered expression of RCA genes has been demonstrated at both the functional and genetic level, but the mechanisms underlying their regulation are not fully characterised. We aimed to investigate the structural organisation of the RCA gene cluster to identify key regulatory elements that influence the expression ofCR2and other genes in this immunomodulatory region. Using 4C, we captured extensive CTCF-mediated chromatin looping across the RCA gene cluster in B cells and showed these were organised into two topologically associated domains (TADs). Interestingly, an inter-TAD boundary was located within theCR1gene at a well-characterised segmental duplication. Additionally, we mapped numerous gene-gene and gene-enhancer interactions across the region, revealing extensive co-regulation. Importantly, we identified an intergenic enhancer and functionally demonstrated this element upregulates two RCA members (CR2andCD55) in B cells. We have uncovered novel, long-range mechanisms whereby autoimmune disease susceptibility may be influenced by genetic variants, thus highlighting the important contribution of chromatin topology to gene regulation and complex genetic disease.